OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Repurposing Metformin in hematologic tumor: State of art
Min Hu, Yan Chen, Tao Ma, et al.
Current Problems in Cancer (2023) Vol. 47, Iss. 4, pp. 100972-100972
Open Access | Times Cited: 7
Min Hu, Yan Chen, Tao Ma, et al.
Current Problems in Cancer (2023) Vol. 47, Iss. 4, pp. 100972-100972
Open Access | Times Cited: 7
Showing 7 citing articles:
Drug Repurposing in Cancer Therapy
Srijita Sen, H. S. Kushwah, Om Prakash Ranjan
Drug repurposing (2024), pp. 57-92
Closed Access | Times Cited: 2
Srijita Sen, H. S. Kushwah, Om Prakash Ranjan
Drug repurposing (2024), pp. 57-92
Closed Access | Times Cited: 2
Metformin as an Enhancer for the Treatment of Chemoresistant CD34+ Acute Myeloid Leukemia Cells
Indre Krastinaite, Sergej Charkavliuk, Rūta Navakauskienė, et al.
Genes (2024) Vol. 15, Iss. 5, pp. 648-648
Open Access | Times Cited: 1
Indre Krastinaite, Sergej Charkavliuk, Rūta Navakauskienė, et al.
Genes (2024) Vol. 15, Iss. 5, pp. 648-648
Open Access | Times Cited: 1
Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma
Melika Hajimohammadebrahim-Ketabforoush, Alireza Zali, Mohammadreza Shahmohammadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Melika Hajimohammadebrahim-Ketabforoush, Alireza Zali, Mohammadreza Shahmohammadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
The use of metformin and risk of myeloproliferative neoplasms among patients with no registered markers of diabetes
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Tarec Christoffer El‐Galaly, et al.
Blood Advances (2024) Vol. 8, Iss. 22, pp. 5932-5934
Open Access
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Tarec Christoffer El‐Galaly, et al.
Blood Advances (2024) Vol. 8, Iss. 22, pp. 5932-5934
Open Access
Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia
Serena Travaglini, Giorgia Silvestrini, Enrico Attardi, et al.
Leukemia Research (2024) Vol. 145, pp. 107568-107568
Open Access
Serena Travaglini, Giorgia Silvestrini, Enrico Attardi, et al.
Leukemia Research (2024) Vol. 145, pp. 107568-107568
Open Access
Dual-signal biosensor based on G-quadruplex/hemin DNAzyme and zinc-doped molybdenum disulfide quantum dots for ultrasensitive detection of tumor biomarker
Jinying Liu, Junyang Chen, Chenyu Zhou, et al.
Talanta (2024) Vol. 283, pp. 127179-127179
Closed Access
Jinying Liu, Junyang Chen, Chenyu Zhou, et al.
Talanta (2024) Vol. 283, pp. 127179-127179
Closed Access
AMPK-mTOR pathway modulates glycolysis reprogramming in unexplained recurrent spontaneous abortion
Yihong Chen, Bei Gan, Shan Zheng, et al.
BMC Pregnancy and Childbirth (2024) Vol. 24, Iss. 1
Open Access
Yihong Chen, Bei Gan, Shan Zheng, et al.
BMC Pregnancy and Childbirth (2024) Vol. 24, Iss. 1
Open Access
